AriBio (AriBio)

Seongnam-si, South Korea

Biotech Therapeutics Drug Development Clinical Development

AriBio is a clinical-stage biotech company located in Seongnam, South Korea focused on developing novel therapeutics for neurodegenerative diseases. The US office is located in San Diego managing global clinical operations and regulatory affairs. The lead asset, AR1001, is entering a global phase 3 program this year.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out AriBio (AriBio) on @MedStartr Today #NeurodegenerativeDiseases #NeurologicalDisorders #Biotech #Therapeutics #DrugDevelopment #ClinicalDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/ZUnOgh1z3DU

Get Involved in AriBio (AriBio)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2010
Website: aribiogroup.com/

Disease Areas

Neurodegenerative Diseases Neurological Disorders

Technologies

BiotherapeuticsDrug DevelopmentClinical Trials

🌐Website

What do you think of AriBio (AriBio)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.